References
Piccolo I, Defanti CA, Soliveri P, Volonte MA, Cislaghi G, Girotti F (2003) Cause and course in a series of patients with sporadic chorea. J Neurol 250(4):429–35
Chatterjee A, Louis ED, Frucht S (2002) Levetiracetam in the treatment of paroxysmal kinesiogenic choreoathetosis. Mov Disord 17:614–615
McGavin CL, Vineeth J, Musser WS (2003) Levetiracetam as a treatment for tardive dyskinesia: a case report. Neurology 61:419–420
Ruegg SJ, Steck AJ, Fuhr P (2004) Levetiracetam improves paroxysmal symptoms in a patient with stiff-person syndrome. Neurology 62(2):338
Hill MP, Bezard E, Mc Guire SG, Crossman AR, Brotchie JM, Michel A, Grimee R, Klitgaard H (2003) Novel antiepileptic drug levetiracetam decrease elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset. Mov Disord 18:1301–1305
Galiano R, Juni J, Castillo A, Parra J, Peiro C, Sancho J (2000) Vascular hemichorea: clinical–radiological correlation. Rev Neurol 30(5):409–411
Johnson WG, Fahn S (1977) Treatment of vascular hemiballism and hemichorea. Neurology 27(7):634–636
Klitgaard H, Matagne A, Grimee R, Vanneste-Goemaere J, Margineanu DG (2003) Electrophysiological, neurochemical and regional effects of levetiracetam in the rat pilocarpine model of temporal lobe epilepsy. Seizure 12:92–100
Margineanu DG, Klitgaard H (2000) Inhibition of neural hypersynchrony in vitro differentiates levetiracetam from classic antiepileptic drugs. Pharmacol Res 42:281–285
Asconape JJ (2002) Some common issues in the use of antiepileptic drugs. Semin Neurol 22(1):27–39
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
D’Amelio, M., Callari, G., Gammino, M. et al. Levetiracetam in the treatment of vascular chorea: a case report. Eur J Clin Pharmacol 60, 835–836 (2005). https://doi.org/10.1007/s00228-004-0842-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-004-0842-0